Toll-Like Receptor와 신장질환 = Toll-Like Receptors and Kidney Diseases

다국어 초록 (Multilingual Abstract)

Toll-like receptors (TLRs) are pattern-recognition receptors which identify pathogens or microorganisms associated molecular patterns (PAMP or MAMP) at the very early stage of their invasion to the host. So TLRs had been known to play a key role in the innate immune system only at first. However, a growing body of evidence that they participate in the adaptive immune system has accumulated as well. Though the primary role of TLRs is the surveillance of invading pathogens and evocation of the innate immune system against them. TLRs, unfortunately, are also found to be involved in pathogenetic processes of many diseases. So over- or under-activation of TLRs is regarded as being related with the course of many diseases. Many kidney diseases including urinary tract infection, sepsis, ischemia- reperfusion injury, acute and chronic renal failure, glomerulonephritides either primary or secondary, and so forth are good examples where TLRs are working seriously. The author summarized the most recent evidences of the relationship between TLRs and the pathogenetic processes of many renal diseases.

참고문헌 (Reference)

1 Patole PS, "Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells" 16 : 1326-1338, 2005

2 Yang CW, "Vandewalle A: Toll-like receptor 2 mediates early inflammation by leptospiral outer membrane proteins in proximal tubule cells" 69 : 815-822, 2006

3 Hung CC, "Upregulation of chemokine CXCL1/KC by leptospiral membrane lipoprotein preparation in renal tubule epithelial cells" 69 : 1814-1822, 2006

4 Fisher CJ Jr, "Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group" 334 : 1697-1702, 1996

5 Barrat FJ, "Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms" 37 : 3582-3586, 2007

6 Shirali AC, "Tracking the toll of kidney disease" 19 : 1444-1450, 2008

7 Brunn GJ, "Toward a modern concept of sepsis: new answers to ancient questions" 6 : 11-17, 2006

8 de Groot K, "Toll‑like receptor 2 and renal allograft function" 28 : 583-588, 2008

9 Salaun B, "Toll-like receptors' two edged sword: when immunity meets apoptosis" 37 : 3311-3318, 2007

10 Robson MG, "Toll-like receptors and renal disease" 113 : 1-7, 2009

11 Eleftheriadis T, "Toll-like receptors and kidney diseases" 8 : 191-201, 2009

12 Wardle EN, "Toll-like receptors and glomerulonephritis" 18 : 159-172, 2007

13 Anders HJ, "Toll-like receptors and danger signaling in kidney injury" 21 : 1270-1274, 2010

14 Pawar RD, "Toll-like receptor-7 modulates immune complex glomerulonephritis" 17 : 141-149, 2006

15 Patole PS, "Toll-like receptor-4: renal cells and bone marrow cells signal for neutrophil recruitment during pyelonephritis" 68 : 2582-2587, 2005

16 Hawn TR, "Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women" 4 : 5990-, 2009

17 Wang S, "Toll-like receptor deficiency reduces chronic allograft nephropathy" 35 : 347-, 2006

18 Iwasaki A, "Toll-like receptor control of the adaptive immune responses" 5 : 987-995, 2004

19 Summers SA, "Toll-like receptor 9 enhances nephritogenic immunity and glomerular leukocyte recruitment, exacerbating experimental crescentic glomerulonephritis" 177 : 2234-2244, 2010

20 Suzuki H, "Toll-like receptor 9 affects severity of IgA nephropathy" 19 : 2384-2395, 2008

21 Christensen SR, "Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus" 25 : 417-428, 2006

22 Schilling JD, "Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli" 100 : 4203-4208, 2003

23 Brown HJ, "Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2" 18 : 1732-1739, 2007

24 Coppo R, "Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin A nephropathy" 159 : 73-81, 2010

25 Brown HJ, "Toll-like receptor 2 agonists exacerbate accelerated nephrotoxic nephritis" 17 : 1931-1939, 2006

26 Lee JS, "Toll-like receptor 1 gene polymorphisms in childhood IgA nephropathy: a case-control study in the Korean population" WILEY-BLACKWELL 38 (38): 133-138, 2011

27 Tipping PG, "Toll-Like receptors: the interface between innate and adaptive immunity" 17 : 1769-1771, 2006

28 Hansson GK, "Toll to be paid at the gateway to the vessel wall" 25 : 1085-1087, 2005

29 Gluba A, "The role of Toll-like receptors in renal diseases" 6 : 224-235, 2010

30 Leemans JC, "The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury" 4 : 5704-, 2009

31 Kudo M, "The role of IFN-gamma and Toll-like receptors in nephropathy induced by Toxoplasma gondii infection" 48 : 617-628, 2004

32 Cervera C, "The influence of innate immunity gene receptors polymorphisms in renal transplant infections" 83 : 1493-1500, 2007

33 Janeway CA Jr, "The immune system evolved to discriminate infectious nonself from noninfectious self" 13 : 11-16, 1992

34 Lemaitre B, "The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults" 86 : 973-983, 1996

35 Matzinger P, "The danger model: a renewed sense of self" 296 : 301-305, 2002

36 Säemann MD, "Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism" 115 : 468-475, 2005

37 Raffi HS, "Tamm- Horsfall protein acts as a general host-defense factor against bacterial cystitis" 25 : 570-578, 2005

38 Banas MC, "TLR4 links podocytes with the innate immune system to mediate glomerular injury" 19 : 704-713, 2008

39 Chassin C, "TLR4 facilitates translocation of bacteria across renal collecting duct cells" 19 : 2364-2374, 2008

40 Wu H, "TLR4 activation mediates kidney ischemia/reperfusion injury" 117 : 2847-2859, 2007

41 Brown HJ, "TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis" 177 : 1925-1931, 2006

42 Shigeoka AA, "TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88- dependent and -independent pathways" 178 : 6252-6258, 2007

43 Soylu A, "TLR-2 Arg753Gln, TLR-4 Asp299Gly, and TLR-4 Thr399Ile polymorphisms in Henoch Schonlein purpura with and without renal involvement" 30 : 667-670, 2010

44 Kawai T, "TLR signaling" 19 : 24-32, 2007

45 Cirl C, "Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/ interleukin-1 receptor domain-containing proteins" 14 : 399-406, 2008

46 Pugin J, "Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock" 104 : 4071-4079, 2004

47 Anders HJ, "Signaling danger: toll-like receptors and their potential roles in kidney disease" 15 : 854-867, 2004

48 Dear JW, "Sepsis-induced organ failure is mediated by different pathways in the kidney and liver: acute renal failure is dependent on MyD88 but not renal cell apoptosis" 69 : 832-836, 2006

49 Cunningham PN, "Role of Toll-like receptor 4 in endotoxin-induced acute renal failure" 172 : 2629-2635, 2004

50 Leemans JC, "Renal‑associated TLR2 mediates ischemia/reperfusion injury in the kidney" 115 : 2894-2903, 2005

51 Leemans JC, "Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney" 115 : 2894-2903, 2005

52 Chassin C, "Renal collecting duct epithelial cells react to pyelonephritis-associated Escherichia coli by activating distinct TLR4-dependent and -independent inflammatory pathways" 177 : 4773-4784, 2006

53 El-Achkar TM, "Renal Toll-like receptors: recent advances and implications for disease" 2 : 568-581, 2006

54 Ducloux D, "Relevance of Toll-like receptor-4 polymorphisms in renal transplantation" 67 : 2454-2461, 2005

55 Ragnarsdóttir B, "Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria" 196 : 475-484, 2007

56 Ando M, "Reduced expression of Toll-like receptor 4 contributes to Impaired cytokine response of monocytes in uremic patients" 70 : 358-362, 2006

57 Barrat FJ, "Nucleic acids of mammalian origin can act as endogenous ligands for toll-like receptors and may promote systemic lupus erythematosus" 202 : 1131-1139, 2005

58 Wörnle M, "Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis" 168 : 370-385, 2006

59 Laso Mdel C, "Mycoplasma pneumoniae detection with PCR in renal tissue of a patient with acute glomerulonephritis" 21 : 1483-1486, 2006

60 Liu G, "Modulation of immune responses through direct activation of Toll-like receptors to T cells" 160 : 168-175, 2010

61 Pawar RD, "Ligands to nucleic acid- specific toll-like receptors and the onset of lupus nephritis" 17 : 3365-3373, 2006

62 윤종우, "Leukocyte Toll-Like Receptor Expression in End-Stage Kidney Disease" 31 (31): 247-254, 201003

63 Sánchez E, "Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus erythematosus" 27 : 267-271, 2009

64 Summers SA, "Intrinsic renal cell and leukocyte-derived TLR4 aggravate experimental anti-MPO glomerulonephritis" 78 : 1263-1274, 2010

65 Pawar RD, "Inhibition of Toll-like receptor- 7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus" 18 : 1721-1731, 2007

66 Reiser J, "Induction of B7-1 in podocytes is associated with nephrotic syndrome" 113 : 1390-1397, 2004

67 Scherberich JE, "Impact of Toll-like receptor signalling on urinary tract infection" 31 (31): 9-14, 2008

68 Hwang YH, "Impact of Polymorphisms of TLR4/CD14 and TLR3 on Acute Rejection in Kidney Transplantation" LIPPINCOTT WILLIAMS WILKINS 88 (88): 699-705, 2009

69 Karoly E, "Heat shock protein 72 (HSPA1B) gene polymorphism and Toll-like receptor (TLR) 4 mutation are associated with increased risk of urinary tract infection in children" 61 : 371-374, 2007

70 De Jager PL, "Genetic variation in toll-like receptor 9 and susceptibility to systemic lupus erythematosus" 54 : 1279-1282, 2006

71 Cheng CH, "Genetic polymorphisms and susceptibility to parenchymal renal infection among pediatric patients" 10 : 1097-, 2010

72 Patole PS, "G-rich DNA suppresses systemic lupus" 16 : 3273-3280, 2005

73 Knotek M, "Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase" 59 : 2243-2249, 2001

74 Beg AA, "Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses" 23 : 509-512, 2002

75 Abraham E, "Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double- blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group" 273 : 934-941, 1995

76 Yoon JW, "Effect of end stage renal disease (ESRD) and hemodialysis (HD) on Toll-like Receptor (TLR) expression and activities" 26 (26): 202-, 2007

77 Palmer SM, "Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation" 20 : 30-36, 2006

78 Poltorak A, "Defective LPS signaling in C3H/HeJ and C57BL/ 10ScCr Mice: Mutations in Tlr4 gene" 282 : 2085-2088, 1998

79 Lartigue A, "Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus" 183 : 6207-6216, 2009

80 Yasuda H, "Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis- induced acute kidney injury" 294 : 1050-1058, 2008

81 Marino MW, "Characterization of tumor necrosis factor-deficient mice" 94 : 8093-8098, 1997

82 Pawar RD, "Bacterial lipopeptide triggers massive albuminuria in murine lupus nephritis by activating Toll-like receptor 2 at the glomerular filtration barrier" 128 (128): 206-221, 2009

83 Schilling JD, "Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism" 166 : 1148-1155, 2001

84 Anders HJ, "Bacterial CpG-DNA aggravates immune complex glomerulonephritis: role of TLR9-mediated expression of chemokines and chemokine receptors" 14 : 317-326, 2003

85 Mutlubas F, "Association between Toll-like receptors 4 and 2 gene polymorphisms with chronic allograft nephropathy in Turkish children" 41 : 1589-1593, 2009

86 Rudofsky G Jr, "Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with a reduced prevalence of diabetic neuropathy in patients with type 2 diabetes" 27 : 179-183, 2004

87 Doi K, "Animal models of sepsis and sepsis-induced kidney injury" 119 : 2868-2878, 2009

88 Huugen D, "Aggravation of anti-myeloperoxidase antibody induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha" 167 : 47-58, 2005

89 Schrier RW, "Acute renal failure and sepsis" 351 : 159-169, 2004

90 Anders HJ, "Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice" 18 : 534-536, 2004

91 Shirali AC, "Activation of the innate immune system by the endogenous ligand hyaluronan" 13 : 20-25, 2008

92 Zhang D, "A toll-like receptor that prevents infection by uropathogenic bacteria" 303 : 1522-1526, 2004

93 Kuroki Y, "A study of innate immunity in patients with end-stage renal disease: special reference to toll-like receptor-2 and -4 expression in peripheral blood monocytes of hemodialysis patients" 19 : 783-790, 2007

94 Medzhitov R, "A human homologue of the Drosophila Toll protein signals activation of adaptive immunity" 388 : 394-397, 1997